Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


Articles published in Ann Neurol

Retrieve available abstracts of 50 articles:
HTML format
Text format



Single Articles


    October 2017
  1. LEE Y, Oh JS, Chung SJ, Chung SJ, et al
    Does Smoking Impact Dopamine Neuronal Loss in de novo Parkinson's Disease?
    Ann Neurol. 2017 Oct 23. doi: 10.1002/ana.25082.
    PubMed     Text format    


  2. CAMACHO-SOTO A, Warden MN, Searles Nielsen S, Salter A, et al
    Traumatic Brain Injury in the Prodromal Period of Parkinson Disease: A Large Epidemiological Study Using Medicare Data.
    Ann Neurol. 2017 Oct 10. doi: 10.1002/ana.25074.
    PubMed     Text format     Abstract available


  3. CHUANG YH, Lee PC, Vlaar T, Mulot C, et al
    Pooled analysis of the HLA-DRB1 by smoking interaction in Parkinson's disease.
    Ann Neurol. 2017 Oct 5. doi: 10.1002/ana.25065.
    PubMed     Text format     Abstract available


  4. SCHONHAUT DR, McMillan CT, Spina S, Dickerson BC, et al
    18 F-flortaucipir tau PET distinguishes established progressive supranuclear palsy from controls and Parkinson's disease: A multicenter study.
    Ann Neurol. 2017 Oct 5. doi: 10.1002/ana.25060.
    PubMed     Text format     Abstract available


    September 2017
  5. STORZER L, Butz M, Hirschmann J, Abbasi O, et al
    Bicycling suppresses abnormal beta synchrony in the Parkinsonian basal ganglia.
    Ann Neurol. 2017 Sep 11. doi: 10.1002/ana.25047.
    PubMed     Text format     Abstract available


  6. STRANIERO L, Guella I, Cilia R, Parkkinen L, et al
    DNAJC12 and dopa-responsive non-progressive Parkinsonism.
    Ann Neurol. 2017 Sep 11. doi: 10.1002/ana.25048.
    PubMed     Text format     Abstract available


    August 2017
  7. IRANZO A, Santamaria J, Valldeoriola F, Serradell M, et al
    Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic REM sleep behavior disorder.
    Ann Neurol. 2017 Aug 22. doi: 10.1002/ana.25026.
    PubMed     Text format     Abstract available


    June 2017
  8. HORN A, Reich M, Vorwerk J, Li N, et al
    Connectivity predicts deep brain stimulation outcome in Parkinson's disease.
    Ann Neurol. 2017 Jun 6. doi: 10.1002/ana.24974.
    PubMed     Text format     Abstract available


    May 2017
  9. MUSACCHIO T, Rebenstorff M, Fluri F, Brotchie JM, et al
    STN-DBS is neuroprotective in the A53T alpha-synuclein Parkinson's disease rat model.
    Ann Neurol. 2017 May 3. doi: 10.1002/ana.24947.
    PubMed     Text format     Abstract available


    April 2017
  10. SEIDEL K, Bouzrou M, Heidemann N, Kruger R, et al
    Involvement of the cerebellum in Parkinson's disease and Dementia with Lewy bodies.
    Ann Neurol. 2017 Apr 25. doi: 10.1002/ana.24937.
    PubMed     Text format     Abstract available


    March 2017
  11. CHEN X, Chen H, Cai W, Maguire M, et al
    The melanoma-linked "redhead" MC1R influences dopaminergic neuron survival.
    Ann Neurol. 2017;81:395-406.
    PubMed     Text format     Abstract available


    February 2017
  12. KAUFMANN H, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, et al
    Natural history of pure autonomic failure: A United States prospective cohort.
    Ann Neurol. 2017;81:287-297.
    PubMed     Text format     Abstract available


    January 2017
  13. KORDOWER JH, Goetz CG, Chu Y, Halliday GM, et al
    Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient.
    Ann Neurol. 2017;81:46-57.
    PubMed     Text format     Abstract available


    December 2016
  14. PAGANO G, Niccolini F, Fusar-Poli P, Politis M, et al
    Serotonin transporter in Parkinson's disease: A meta-analysis of PET studies.
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24859.
    PubMed     Text format     Abstract available


  15. BRAKEDAL B, Haugarvoll K, Tzoulis C
    Simvastatin is associated with decreased risk of Parkinson Disease.
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24857.
    PubMed     Text format    


  16. YEN SJ, Lin KD
    Reply to "Simvastatin is associated with decreased risk of Parkinson Disease" by Brage Brakedal.
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24862.
    PubMed     Text format    


    October 2016
  17. LIN KD, Shin SJ
    Reply to 'Risk reduction of Parkinson disease by statin therapy in patients with diabetes' by T. Kawada.
    Ann Neurol. 2016 Oct 31. doi: 10.1002/ana.24813.
    PubMed     Text format    


  18. KAWADA T
    Risk reduction of Parkinson disease by statin therapy in patients with diabetes.
    Ann Neurol. 2016 Oct 27. doi: 10.1002/ana.24809.
    PubMed     Text format    


  19. STANDAERT DG, Geldmacher DS
    GBA, Parkinson disease, and the "senses and intellect".
    Ann Neurol. 2016 Oct 25. doi: 10.1002/ana.24808.
    PubMed     Text format    


  20. INZELBERG R, Flash S, Friedman E, Azizi E, et al
    Cutaneous malignant melanoma and Parkinson's disease: common pathways?
    Ann Neurol. 2016 Oct 19. doi: 10.1002/ana.24802.
    PubMed     Text format     Abstract available


    September 2016
  21. LIU G, Boot B, Locascio JJ, Jansen IE, et al
    Neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.
    Ann Neurol. 2016 Sep 22. doi: 10.1002/ana.24781.
    PubMed     Text format     Abstract available


  22. CILIA R, Tunesi S, Marotta G, Cereda E, et al
    Survival and dementia in GBA-associated Parkinson Disease: The mutation matters.
    Ann Neurol. 2016 Sep 15. doi: 10.1002/ana.24777.
    PubMed     Text format     Abstract available


    July 2016
  23. LIN KD, Yang CY, Lee MY, Ho SC, et al
    Statin Therapy Prevents the Onset of Parkinson Disease in Patients with Diabetes.
    Ann Neurol. 2016 Jul 29. doi: 10.1002/ana.24751.
    PubMed     Text format     Abstract available


    June 2016
  24. MITROFANIS J, Moro C, Benabid AL
    Further analysis of the neuroprotective effect of near-infrared light in a monkey model of Parkinson disease.
    Ann Neurol. 2016 Jun 4. doi: 10.1002/ana.24696.
    PubMed     Text format    


    April 2016
  25. GUELLA I, Evans DM, Szu-Tu C, Nosova E, et al
    alpha-synuclein genetic variability: A biomarker for dementia in Parkinson's disease.
    Ann Neurol. 2016 Apr 18. doi: 10.1002/ana.24664.
    PubMed     Text format     Abstract available


  26. JIANG T, Zhang YD, Tan L, Yu JT, et al
    DNAJC6 variants in Parkinson's disease and amyotrophic lateral sclerosis.
    Ann Neurol. 2016 Apr 4. doi: 10.1002/ana.24658.
    PubMed     Text format    


    March 2016
  27. STOKHOLM MG, Danielsen EH, Hamilton-Dutoit SJ, Borghammer P, et al
    Pathological alpha-synuclein in gastrointestinal tissues from prodromal parkinson's disease patients.
    Ann Neurol. 2016 Mar 26. doi: 10.1002/ana.24648.
    PubMed     Text format     Abstract available


  28. TELL-MARTI G, Anton Puig-Butille J, Potrony M, Badenas C, et al
    Reply to Letter to Editor ANA-16-0021 'Lack of association between MC1R variants and Parkinson's disease in European descent' by Jiang Q and Liu G.
    Ann Neurol. 2016 Mar 2. doi: 10.1002/ana.24629.
    PubMed     Text format    


  29. JIANG Q, Liu G
    Lack of association between MC1R variants and Parkinson's disease in European descent.
    Ann Neurol. 2016 Mar 2. doi: 10.1002/ana.24627.
    PubMed     Text format    


    December 2015
  30. ELSAYED LE, Drouet V, Usenko T, Mohammed IN, et al
    A novel nonsense mutation in DNAJC6 expands the phenotype of autosomal recessive juvenile-onset Parkinson disease.
    Ann Neurol. 2015 Dec 24. doi: 10.1002/ana.24591.
    PubMed     Text format    


  31. POSTON KL, YorkWilliams S, Zhang K, Cai W, et al
    Compensatory Neural Mechanisms in Cognitively Unimpaired Parkinson's Disease.
    Ann Neurol. 2015 Dec 22. doi: 10.1002/ana.24585.
    PubMed     Text format     Abstract available


  32. LORENZO-BETANCOR O, Wszolek ZK, Ross OA
    Rare variants in MC1R/TUBB3 exon 1 are not associated with Parkinson's disease.
    Ann Neurol. 2015 Dec 17. doi: 10.1002/ana.24581.
    PubMed     Text format    


    November 2015
  33. DONADIO V, Incensi A, Piccinini C, Cortelli P, et al
    Skin nerve misfolded alpha-synuclein in pure autonomic failure and Parkinson disease.
    Ann Neurol. 2015 Nov 25. doi: 10.1002/ana.24567.
    PubMed     Text format     Abstract available


  34. GRUNEWALD A, Rygiel KA, Hepplewhite PD, Morris CM, et al
    Mitochondrial DNA depletion in respiratory chain-deficient Parkinson disease neurons.
    Ann Neurol. 2015 Nov 25. doi: 10.1002/ana.24571.
    PubMed     Text format     Abstract available


  35. OLGIATI S, Quadri M, Fang M, Rood JP, et al
    DNAJC6 mutations associated with early-onset Parkinson's disease.
    Ann Neurol. 2015 Nov 3. doi: 10.1002/ana.24553.
    PubMed     Text format     Abstract available


    October 2015
  36. DARLOT F, Moro C, El Massri N, Chabrol C, et al
    Near-infrared light is neuroprotective in a monkey model of Parkinson's disease.
    Ann Neurol. 2015 Oct 11. doi: 10.1002/ana.24542.
    PubMed     Text format     Abstract available


  37. KAUFMANN H
    Cutting the vagal highway blocks one point of entry for prion-like alpha-synuclein.
    Ann Neurol. 2015;78:520-1.
    PubMed     Text format    


    September 2015
  38. TYSNES OB, Kenborg L, Herlofson K, Steding-Jessen M, et al
    Does vagotomy reduce the risk of Parkinson's disease?
    Ann Neurol. 2015 Sep 29. doi: 10.1002/ana.24531.
    PubMed     Text format    


  39. LUBBE SJ, Escott-Price V, Brice A, Gasser T, et al
    Is the MC1R variant p.R160W associated with Parkinson's?
    Ann Neurol. 2015 Sep 21. doi: 10.1002/ana.24527.
    PubMed     Text format    


  40. TELL-MARTI G, Puig-Butille JA, Potrony M, Badenas C, et al
    Reply to Letter to Editor ANA-15-1051 'Is the MC1R variant p.R160W associated with Parkinson's?' by Lubbe SJ, Escott-Price V, Brice A, et al.
    Ann Neurol. 2015 Sep 21. doi: 10.1002/ana.24526.
    PubMed     Text format    


  41. SVENSSON E, Horvath-Puho E, Thomsen RW, Djurhuus JC, et al
    Does vagotomy reduce the risk of Parkinson's disease - the authors reply.
    Ann Neurol. 2015 Sep 15. doi: 10.1002/ana.24518.
    PubMed     Text format    


  42. PYLE A, Brennan R, Kurzawa-Akanbi M, Yarnall A, et al
    Reduced CSF mitochondrial DNA is a biomarker for early-stage Parkinson's disease.
    Ann Neurol. 2015 Sep 7. doi: 10.1002/ana.24515.
    PubMed     Text format     Abstract available


    August 2015
  43. SWANN NC, de Hemptinne C, Aron AR, Ostrem JL, et al
    Elevated synchrony in Parkinson's disease detected with electroencephalography.
    Ann Neurol. 2015 Aug 20. doi: 10.1002/ana.24507.
    PubMed     Text format     Abstract available


  44. NAZERI A, Roostaei T, Sadaghiani S, Chakravarty MM, et al
    Genome-wide variant by serum urate interaction in Parkinson's Disease.
    Ann Neurol. 2015 Aug 18. doi: 10.1002/ana.24504.
    PubMed     Text format     Abstract available


  45. GRAY MT, Munoz DG, Schlossmacher MG, Gray DA, et al
    Protective effect of vagotomy suggests source organ for Parkinson's disease.
    Ann Neurol. 2015 Aug 12. doi: 10.1002/ana.24501.
    PubMed     Text format    


  46. SVENSSON E, Horvath-Puho E, Thomsen RW, Djurhuus JC, et al
    Re: Protective effect of vagotomy suggests source organ for Parkinson's disease.
    Ann Neurol. 2015 Aug 12. doi: 10.1002/ana.24500.
    PubMed     Text format    


    July 2015
  47. TELL-MARTI G, Puig-Butille JA, Potrony M, Badenas C, et al
    Reply: To PMID 25631192.
    Ann Neurol. 2015;78:153-4.
    PubMed     Text format    


  48. VANDERHORST VG, Samardzic T, Saper CB, Anderson MP, et al
    alpha-Synuclein pathology accumulates in sacral spinal visceral sensory pathways.
    Ann Neurol. 2015;78:142-9.
    PubMed     Text format     Abstract available


    June 2015
  49. WARREN OLANOW C, Bartus RT, Baumann TL, Factor S, et al
    Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.
    Ann Neurol. 2015 Jun 10. doi: 10.1002/ana.24436.
    PubMed     Text format     Abstract available


    May 2015
  50. SVENSSON E, Horvath-Puho E, Thomsen RW, Djurhuus JC, et al
    Vagotomy and subsequent risk of Parkinson's disease.
    Ann Neurol. 2015 May 29. doi: 10.1002/ana.24448.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: